PARGi

Best-in-class PARG inhibitor: Exploiting DNA repair in tumours with specific vulnerabilities

Nodus Oncology has developed novel, potent small molecule inhibitors of PARG with significant tumour growth inhibition in vivo.

Would you like to learn more about Nodus Oncology?